MRVL Stock Analysis: Marvell Technology | NASDAQ
Semiconductors | NASDAQ, USA | Market Cap: 214.580m USD | 12M Return: 243.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 16.6B
EPS Trend: 85.0%
Qual. Beats: 3
Rev. Trend: 88.5%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Marvell Technology, Inc. is a U.S.-headquartered semiconductor company that designs data infrastructure solutions spanning from the data center core to the network edge. The company develops system-on-chip (SoC) architectures that integrate analog, mixed-signal, and digital signal processing functionality, and sells a broad portfolio of ethernet switches and controllers, custom ASICs, processors, fibre channel products, storage controllers for HDDs and SSDs, and interconnect solutions including coherent DSPs, silicon photonics, and co-packaged optics. Its products serve data center, communications, and adjacent markets, and are sold through both direct customers and distributors across the U.S., Argentina, China, India, Israel, Japan, Singapore, South Korea, Taiwan, and Vietnam. The company was incorporated in 1995 and is based in Wilmington, Delaware.
Marvell operates as a fabless semiconductor designer, outsourcing wafer fabrication to foundries and focusing internal resources on chip design, IP, and software-an industry model that reduces capital expenditure requirements but creates dependence on third-party manufacturing capacity. Its product mix is closely tied to cloud computing and hyperscale data center buildouts, where demand for high-speed networking, optical interconnects, and custom silicon has grown alongside the expansion of AI and machine learning workloads.
- Custom ASIC revenue surges on hyperscaler AI infrastructure spend
- Data center ethernet demand accelerates from AI cluster buildouts
- China sales face potential export control restrictions
| Net Income: 2.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.67 > 1.0 |
| NWC/Revenue: 59.51% < 20% (prev 13.78%; Δ 45.72% < -1%) |
| CFO/TA 0.08 > 3% & CFO 2.06b > Net Income 2.53b |
| Net Debt (1.75b) to EBITDA (4.62b): 0.38 < 3 |
| Current Ratio: 3.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (893.3m) vs 12m ago 2.02% < -2% |
| Gross Margin: 50.64% > 18% (prev 43.17%; Δ 7.47% > 0.5%) |
| Asset Turnover: 37.12% > 50% (prev 32.47%; Δ 4.65% > 0%) |
| Interest Coverage Ratio: 15.80 > 6 (EBIT TTM 3.34b / Interest Expense TTM 211.2m) |
| A: 0.19 (Total Current Assets 7.46b - Total Current Liabilities 2.28b) / Total Assets 26.9b |
| B: 0.05 (Retained Earnings 1.34b / Total Assets 26.9b) |
| C: 0.14 (EBIT TTM 3.34b / Avg Total Assets 23.5b) |
| D: 2.09 (Book Value of Equity 18.2b / Total Liabilities 8.73b) |
| Altman-Z'' = 4.57 = AA |
| DSRI: 1.22 (Receivables 1.87b/1.14b, Revenue 8.72b/6.50b) |
| GMI: 0.85 (GM 43.17% / 50.64%) |
| AQI: 0.89 (AQ_t 0.68 / AQ_t-1 0.76) |
| SGI: 1.34 (Revenue 8.72b / 6.50b) |
| TATA: 0.02 (NI 2.53b - CFO 2.06b) / TA 26.9b) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of July 07, 2026, the stock is trading at USD 245.29 with a total of 38,579,900 shares traded. Over the past week, the price has changed by -12.79%, over one month by -6.90%, over three months by +124.10% and over the past year by +243.75%.
Current recommended Stop Loss: 210.10 (which is 14.3% or 1.3 ATR below the current price).
Marvell Technology has received a consensus analysts rating of 4.49. Therefore, it is recommended to buy MRVL.
- StrongBuy: 23
- Buy: 9
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 249.3 | 1.6% |
P/E Trailing = 84.0034
P/E Forward = 67.1141
P/S = 24.616
P/B = 13.065
P/EG = 1.5375
Revenue TTM = 8.72b USD
EBIT TTM = 3.34b USD
EBITDA TTM = 4.62b USD
Long Term Debt = 4.96b USD (from longTermDebt, last quarter)
Short Term Debt = 54.5m USD (from shortTermDebt, last quarter)
Debt = 5.59b USD (from shortLongTermDebtTotal, last quarter) + Leases 315.9m
Net Debt = 1.75b USD (calculated: Debt 5.59b - CCE 3.84b)
Enterprise Value = 216b USD (215b + Debt 5.59b - CCE 3.84b)
Interest Coverage Ratio = 15.80 (Ebit TTM 3.34b / Interest Expense TTM 211.2m)
EV/FCF = 130.0x (Enterprise Value 216b / FCF TTM 1.66b)
FCF Yield = 0.77% (FCF TTM 1.66b / Enterprise Value 216b)
FCF Margin = 19.09% (FCF TTM 1.66b / Revenue TTM 8.72b)
Net Margin = 28.99% (Net Income TTM 2.53b / Revenue TTM 8.72b)
Gross Margin = 50.64% ((Revenue TTM 8.72b - Cost of Revenue TTM 4.30b) / Revenue TTM)
Gross Margin QoQ = 52.15% (prev 48.37%)
Tobins Q-Ratio = 8.03 (Enterprise Value 216b / Total Assets 26.9b)
Interest Expense / Debt = 3.78% (Interest Expense 211.2m / Debt 5.59b)
Taxrate = 13.29% (387.3m / 2.91b)
NOPAT = 2.89b (EBIT 3.34b * (1 - 13.29%))
Current Ratio = 3.28 (Total Current Assets 7.46b / Total Current Liabilities 2.28b)
Debt / Equity = 0.31 (Debt 5.59b / totalStockholderEquity, last quarter 18.2b)
Debt / EBITDA = 0.38 (Net Debt 1.75b / EBITDA 4.62b)
Debt / FCF = 1.05 (Net Debt 1.75b / FCF TTM 1.66b)
Total Stockholder Equity = 15.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.76% (Net Income 2.53b / Total Assets 26.9b)
RoE = 16.84% (Net Income TTM 2.53b / Total Stockholder Equity 15.0b)
RoCE = 16.72% (EBIT 3.34b / Capital Employed (Equity 15.0b + L.T.Debt 4.96b))
RoIC = 11.91% (NOPAT 2.89b / Invested Capital 24.3b)
WACC = 16.75% (E(215b)/V(220b) * Re(17.10%) + D(5.59b)/V(220b) * Rd(3.78%) * (1-Tc(0.13)))
Discount Rate = 17.10% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 40.45 | Cagr: 1.46%
[DCF] Terminal Value 55.51% ; FCFF base≈1.55b ; Y1≈1.77b ; Y5≈2.61b
[DCF] Fair Price = 15.82 (EV 15.6b - Net Debt 1.75b = Equity 13.8b / Shares 874.8m; r=16.75% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 85.00 | EPS CAGR: 31.64% | SUE: 1.32 | # QB: 3
Revenue Correlation: 88.48 | Revenue CAGR: 20.04% | SUE: 0.48 | # QB: 0
EPS current Quarter (2026-07-31): EPS=0.93 | Chg30d=+0.04% | Revisions=+71% | Analysts=33
EPS next Quarter (2026-10-31): EPS=1.07 | Chg30d=+0.09% | Revisions=+91% | Analysts=31
EPS current Year (2027-01-31): EPS=4.05 | Chg30d=+0.45% | Revisions=+88% | GrowthEPS=+42.6% | GrowthRev=+40.7%
EPS next Year (2028-01-31): EPS=6.18 | Chg30d=+1.69% | Revisions=+92% | GrowthEPS=+52.6% | GrowthRev=+44.8%
[Analyst] Revisions Ratio: +92% (up=127, down=4)